Relationship of cognitive measures and gray and white matter in Alzheimer's disease
- PMID: 16914835
- DOI: 10.3233/jad-2006-9304
Relationship of cognitive measures and gray and white matter in Alzheimer's disease
Abstract
Objective: To examine the relationship between commonly used screening cognitive measures with gray and white matter integrity in patients with mild to moderate AD.
Background: New neuroimaging techniques, such as voxel-based morphometry (VBM), make it possible to study the relationship between structural brain integrity and cognitive functioning in AD.
Methods: Gray and white matter integrity was evaluated using VBM in fifteen patients with mild to moderate AD. ADAS-Cog and MMSE scores were also performed as part of the baseline assessment for a larger clinical trial in the AD patients. Correlations between cognitive measures and VBM were performed.
Results: Both the ADAS-Cog and the MMSE showed a similar relationship with gray matter degeneration, reflecting greater cognitive impairment with decreased gray matter in the left temporal lobe. However, the MMSE score was much more reflective of underlying white matter changes than ADAS-Cog scores, particularly in frontotemporal region. These findings suggest that the ADAS-Cog and MMSE reflect different aspects of the underlying brain changes observed in AD. The ADAS-Cog was more specific to gray matter integrity whereas the MMSE reflected a more global reduction in both gray and white matter.
Conclusions: These results support using neuroimaging markers of neural integrity as an important consideration when evaluating treatment efficacy. Furthermore, whole-brain analyses such as VBM help to evaluate neural systems that are not necessarily targeted by the treatment.
Comment in
-
Voxel-based morphometry in Alzheimer's patients.J Alzheimers Dis. 2006 Dec;10(4):445-7; discussion 449. doi: 10.3233/jad-2006-10414. J Alzheimers Dis. 2006. PMID: 17183157 No abstract available.
Similar articles
-
The Neuropsychological Correlates of Brain Perfusion and Gray Matter Volume in Alzheimer's Disease.J Alzheimers Dis. 2020;78(4):1639-1652. doi: 10.3233/JAD-200676. J Alzheimers Dis. 2020. PMID: 33185599
-
Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative.Arch Neurol. 2010 Nov;67(11):1370-8. doi: 10.1001/archneurol.2010.284. Arch Neurol. 2010. PMID: 21060014 Free PMC article. Clinical Trial.
-
Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.Brain Topogr. 2019 Jan;32(1):142-160. doi: 10.1007/s10548-018-0675-2. Epub 2018 Sep 11. Brain Topogr. 2019. PMID: 30206799
-
[Volumetry of cerebral gray and white matter using VSRAD®].Brain Nerve. 2015 Apr;67(4):487-96. doi: 10.11477/mf.1416200165. Brain Nerve. 2015. PMID: 25846597 Review. Japanese.
-
Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease.J Int Neuropsychol Soc. 2006 Sep;12(5):707-35. doi: 10.1017/S1355617706060863. J Int Neuropsychol Soc. 2006. PMID: 16961952 Free PMC article. Review.
Cited by
-
A technical review of canonical correlation analysis for neuroscience applications.Hum Brain Mapp. 2020 Sep;41(13):3807-3833. doi: 10.1002/hbm.25090. Epub 2020 Jun 27. Hum Brain Mapp. 2020. PMID: 32592530 Free PMC article.
-
Cloud-Based Brain Magnetic Resonance Image Segmentation and Parcellation System for Individualized Prediction of Cognitive Worsening.J Healthc Eng. 2019 Jan 29;2019:9507193. doi: 10.1155/2019/9507193. eCollection 2019. J Healthc Eng. 2019. PMID: 30838124 Free PMC article.
-
The global research of magnetic resonance imaging in Alzheimer's disease: a bibliometric analysis from 2004 to 2023.Front Neurol. 2025 Jan 15;15:1510522. doi: 10.3389/fneur.2024.1510522. eCollection 2024. Front Neurol. 2025. PMID: 39882364 Free PMC article.
-
Predicting clinical scores from magnetic resonance scans in Alzheimer's disease.Neuroimage. 2010 Jul 15;51(4):1405-13. doi: 10.1016/j.neuroimage.2010.03.051. Epub 2010 Mar 25. Neuroimage. 2010. PMID: 20347044 Free PMC article.
-
Genetic polymorphism in β-site amyloid precursor protein-cleaving enzyme 1 affects the structure of medial temporal lobe and cognition in Alzheimer's disease: an exploratory study.Eur Arch Psychiatry Clin Neurosci. 2024 Dec 28. doi: 10.1007/s00406-024-01953-2. Online ahead of print. Eur Arch Psychiatry Clin Neurosci. 2024. PMID: 39733191
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical